跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,596 条关于
“Shift Bio”
全部
9,596
临床试验
2,906
药物
1,030
机构
275
资讯
5,385
去年
FDA Signals Potential Shift in Biosimilar Development Requirements, Moving Away from Phase III Trials
去年
US Biotech Companies Shift Clinical Trials Abroad Amid FDA Uncertainty
去年
Exosome Therapeutics Field Advances Toward Clinical Trials as Industry Prepares for Regulatory Milestones
11个月前
Biopharma M&A Activity Surges in Q3 2025 with $55.7 Billion in Acquisitions
去年
NGM Bio Licenses NGM313 to KdT Ventures for Rare Disease Development
上个月
Biogen Beats Q2 Estimates as Rare Disease Portfolio and Leqembi Drive Growth, Raises 2026 Revenue Outlook
14天前
Frost & Sullivan 2026 Blue Book Charts Hong Kong 18A Biotech Sector's Shift Toward Value-Driven Growth
去年
Deerfield Management Raises Over $600M for Third Biotech Innovation Fund
9年前
Celltrion Pursues Novel Multi-Brand Strategy for Rituximab Biosimilar in EU Market
5个月前
Biopharma Firms Shift FDA-Approved Drug Manufacturing to Europe Despite US Tariffs, Widening Outsourcing Gap to Historic Levels
第 1 页,共 539 页
上一页
下一页